Marta Ramírez‐Huesca

Author

Hospital Universitario de La Princesa ORCID

Also Known As

M Ramrez-Huesca, M Ramírez-Huesca, M. Ramírez-Huesca, Marta Ramirez-Huesca, Marta Ramírez-Huesca, Marta Ramírez‐Huesca

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de La Princesa Universidad Autónoma de Madrid Spanish National Centre for Cardiovascular Research Centro de Investigación en Red en Enfermedades Cardiovasculares Centro de Investigación Biomédica en Red

About

Marta Ramírez‐Huesca is an author at Hospital Universitario de La Princesa specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	750
2	Cell Biology	5	5	357
3	Allergy	2	2	168
4	Biomedical Engineering	2	2	283
5	Engineering	1	1	212

Marta Ramírez‐Huesca

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells Marı́a Yáñez-Mó, Enrique Lara‐Pezzi, Rafael Selgas, New England Journal of Medicine	2003	767
Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor Luiz Stark Aroeira, Abelardo Aguilera, Rafael Selgas, American Journal of Kidney Diseases Regenerative MedicineMechanobiologyHemodialysisRenal FunctionEngineering	2005	212
Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation Danay Cibrián, Raquel Castillo‐González, Nieves Fernández‐Gallego, Journal of Allergy and Clinical Immunology	2019	135
CD69 Association with Jak3/Stat5 Proteins Regulates Th17 Cell Differentiation Pilar Martı́n, Manuel Gómez‐Florit, Amalia Lamana, Molecular and Cellular Biology Lymphocyte DevelopmentImmunologyImmune RegulationType Ii CollagenImmunologic Mechanism	2010	126
BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure Jesús Loureiro, Margot N. Schilte, Abelardo Aguilera, Nephrology Dialysis Transplantation	2010	101
CD69 Limits the Severity of Cardiomyopathy After Autoimmune Myocarditis Aránzazu Cruz‐Adalia, Luis Jesús Jiménez‐Borreguero, Marta Ramírez‐Huesca, Circulation	2010	97
The Leukocyte Activation Receptor CD69 Controls T Cell Differentiation through Its Interaction with Galectin-1 Hortensia de la Fuente, Aránzazu Cruz‐Adalia, Gloria Martı́nez del Hoyo, Molecular and Cellular Biology Lymphocyte DevelopmentT-regulatory CellImmune RegulationImmunologyImmunologic Mechanism	2014	96
Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses Sara G. Dosil, Sheila López‐Cobo, Ana Rodríguez‐Galán, eLife	2022	78
The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity Pilar Martı́n, Manuel Gómez‐Florit, Amalia Lamana, Journal of Allergy and Clinical Immunology AsthmaInflammationAllergySkin Contact HypersensitivityImmunology	2010	72
Ex Vivo Analysis of Dialysis Effluent-Derived Mesothelial Cells as an Approach to Unveiling the Mechanism of Peritoneal Membrane Failure Manuel López‐Cabrera, Abelardo Aguilera, Luiz Stark Aroeira, Peritoneal Dialysis International DialysisPathologyDialysis TherapyBiomedical EngineeringEx Vivo Analysis	2006	71

Page 1